The U.S. Senate approved bipartisan legislation that would ease restrictions on medical marijuana-related research, sending to President Joe Biden’s desk the first of what the cannabis industry hopes is a flurry of MJ-related bills over the next month.
It’s also the first time Congress has passed a bill solely related to marijuana.
ADVERTISEMENT
The bill, which had support from Sens. Chuck Grassley, R-Iowa, and Dianne Feinstein, D-California – the two were for years considered obstacles to marijuana reform – passed the Senate on Wednesday without a vote via a process called unanimous consent.
Passed by the House in July, the Medical Marijuana and Cannabidiol Research Expansion Act would allow research universities as well as private companies, including pharmaceutical firms, to acquire U.S. Drug Enforcement Administration licenses to grow and handle cannabis for scientific purposes.
From 1968 until 2021, the only institution in the United States allowed to
Read full article on Marijuana Business Daily